Haitao Chen

5PUBLICATIONS
44CO-AUTHORS
Powder and particle technologyHaematologyRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 23, 2025
Structural basis for psilocybin biosynthesis.

Chunyan Meng, Wenting Guo, Chuan Xiao

|Mar 14, 2025
HLA-DQB1*03:01 and risk of HBV-related HCC.

Ting Zhang, Chih-Jen Huang, Hai-Tao Chen

|Mar 10, 2023
Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy.

Yongyin Li, Chunhua Wen, Shuqin Gu

|Jul 25, 2022
TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients.

Mengqi Luo, Jia Hou, Haoming Mai

|Jan 17, 2020
A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients.

Haitao Chen, Jian Sun, Bin Zhou

Pageof 1

Frequent Collaborators

4 joint publications

Deke Jiang

3 joint publications

Jinlin Hou

1 joint publications

Ting Zhang

1 joint publications

Chih-Jen Huang